Advanced imaging support for clinical trials
Imaging Core
This program provides expert PET/MRI imaging and analysis for clinical trials enrolling people with artery plaque and related vascular conditions.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11137000 on NIH RePORTER |
What this research studies
This Imaging Core at Mount Sinai runs the scanners, creates and updates imaging protocols, and handles image analysis and data management for the program. An expert panel of imaging scientists and analysts will standardize methods across projects and review protocols as studies progress. The core will store and share imaging data and will act as the imaging operations center for a two-center human clinical trial in the program. Dedicated image analysts and data managers will perform image processing, quality control, and long-term data archiving to support reliable results.
Who could benefit from this research
Good fit: Ideal candidates are people enrolled in the program's clinical trials, especially those with atherosclerosis, arterial plaque, or suspected vascular inflammation who need PET/MRI imaging.
Not a fit: People without vascular disease, those who cannot undergo PET/MRI (for example due to pregnancy, severe claustrophobia, or incompatible implants), or those far from participating sites are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, the core could help doctors better see and track artery plaque and treatment effects by providing more consistent, high-quality imaging and analysis.
How similar studies have performed: Using 18F-FDG PET and standardized image analysis to detect arterial inflammation has been used successfully in prior studies, so this core builds on established imaging methods.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Robson, Philip Martyn — Icahn School of Medicine at Mount Sinai
- Study coordinator: Robson, Philip Martyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.